Who are in the management team of NGL Fine Chem?

As of March 2023, the management team of NGL Fine Chem includes Rahul J Nachane (Managing Director), Rajesh N Lawande (Whole Time Director & CFO), Milind V Shinde (Chairman & Independent Director), Ajita Nachane (Non-Executive Director), Jayaram Sitaram (Non-Executive Independent Director), Pallavi Pednekar (Company Secretary), and Sarala Menon (Independent Director). They oversee the company's operations and strategic direction.

As of March 2023, the management team of NGL Fine Chem includes the following individuals:<BR><BR>1. Rahul J Nachane - Managing Director<BR>2. Rajesh N Lawande - Whole Time Director & CFO<BR>3. Milind V Shinde - Chairman & Independent Director<BR>4. Ajita Nachane - Non-Executive & Non-Independent Director<BR>5. Jayaram Sitaram - Non-Executive & Independent Director<BR>6. Pallavi Pednekar - Company Secretary & Compliance Officer<BR>7. Sarala Menon - Independent Director<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

Has NGL Fine Chem declared dividend?

NGL Fine Chem Ltd has declared a 35% dividend, amounting to ₹1.75 per share, with an ex-date of August 16, 2024. While recent total returns have been negative, the company has shown significant positive returns over the past five years.

NGL Fine Chem Ltd has declared a 35% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 35%<BR>- Amount per share: 1.75<BR>- Ex-date: 16 Aug 24<BR><BR>Dividend Yield: 0.17%.<BR><BR>Total Returns by Period:<BR>In the 6 months period, the price return was -42.05%, with a dividend return of 0%, resulting in a total return of -42.05%.<BR><BR>Over the 1 year period, the price return was -53.0%, accompanied by a dividend return of 0.07%, leading to a total return of -52.93%.<BR><BR>For the 2 years period, the price return was -27.5%, with a dividend return of 0.21%, culminating in a total return of -27.29%.<BR><BR>In the 3 years period, the price return was -41.37%, and the dividend return was 0.21%, resulting in a total return of -41.16%.<BR><BR>During the 4 years period, the price return was -44.93%, with a dividend return of 0.34%, leading to a total return of -44.59%.<BR><BR>In the 5 years period, the price return was 163.89%, accompanied by a dividend return of 2.62%, resulting in a total return of 166.51%.<BR><BR>Overall, while NGL Fine Chem has declared a dividend, the total returns over the shorter periods have been negative, indicating a challenging performance. However, the longer-term returns over five years show a significant positive return, suggesting potential recovery or growth in the future.

Who are the peers of the NGL Fine Chem?

NGL Fine Chem's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, Venus Remedies, Shukra Pharma, Nectar Lifesci, Medicamen Biotec, and Sakar Healthcare. NGL Fine Chem has average management risk, below-average growth, and the lowest 1-year return at -52.32% among its peers.

Peers: The peers of NGL Fine Chem are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Venus Remedies, Shukra Pharma., Nectar Lifesci., Medicamen Biotec, and Sakar Healthcare.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Average management risk is found at NGL Fine Chem, Venus Remedies, Shukra Pharma., Medicamen Biotec, and Sakar Healthcare. Growth is Excellent for Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Below Average growth is seen at NGL Fine Chem, Divi's Lab., Torrent Pharma, Nectar Lifesci., and Medicamen Biotec. Capital Structure is Excellent for Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, NGL Fine Chem, Venus Remedies, and Medicamen Biotec, while Good capital structure is noted for Torrent Pharma and Shukra Pharma., and Average for Sakar Healthcare.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while NGL Fine Chem has the lowest at -52.32%. NGL Fine Chem's return is significantly lower than all its peers. Additionally, Nectar Lifesci., Medicamen Biotec, and NGL Fine Chem have negative six-month returns.

What does NGL Fine Chem do?

NGL Fine Chem Ltd is a Micro Cap manufacturer of pharmaceuticals and intermediates for veterinary and human health, with net sales of 950 Cr and a net profit of 5 Cr as of March 2025. The company was incorporated in 1981 and is based in Mumbai, India.

Overview:<BR>NGL Fine Chem Ltd is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap company.<BR><BR>History:<BR>NGL Fine Chem Ltd was incorporated on December 18, 1981, initially as a Private Limited Company in Maharashtra and later became a Public Limited Company. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 950 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 5 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 891 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 43.00 <BR>Industry P/E: 37 <BR>Dividend Yield: 0.13% <BR>Debt-Equity: 0.03 <BR>Return on Equity: 7.38% <BR>Price to Book: 3.00 <BR><BR>Contact Details:<BR>Address: 301 E Square Subhash Road, Vile Parle (East) Mumbai Maharashtra : 400057 <BR>Tel: +91-22-2663 6450 <BR>Email: cs@nglfinechem.com / info@nglfinechem.com <BR>Website: http://www.nglfinechem.com

Who are the top shareholders of the NGL Fine Chem?

The top shareholder of NGL Fine Chem is Rajesh Lawande, holding 21.89%, with no pledged promoter holdings. Public shareholders include Yashkumar Poonamchand Golechha at 1.05%, while individual investors collectively hold 22.75%; mutual funds and foreign institutional investors have negligible holdings.

The top shareholders of NGL Fine Chem primarily include the promoters, with Rajesh Lawande holding the largest share at 21.89%. There are no pledged promoter holdings. In terms of public shareholders, Yashkumar Poonamchand Golechha is the highest individual shareholder at 1.05%. Additionally, individual investors collectively hold 22.75% of the company's shares. Mutual funds and foreign institutional investors have minimal holdings, with mutual funds holding 0.0% and only one foreign institutional investor also holding 0.0%.

How big is NGL Fine Chem?

As of 24th July, NGL Fine Chem Ltd has a market capitalization of 791.00 Cr, with net sales of 368.30 Cr and a net profit of 20.85 Cr for the latest four quarters. Shareholder's funds are 262.63 Cr and total assets amount to 355.54 Cr as of March 2024.

As of 24th July, NGL Fine Chem Ltd has a market capitalization of 791.00 Cr, categorizing it as a Micro Cap company.<BR><BR>For the latest four quarters, NGL Fine Chem reported Net Sales of 368.30 Cr and a Net Profit of 20.85 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 262.63 Cr and Total Assets of 355.54 Cr.

Are NGL Fine Chem latest results good or bad?

NGL Fine Chem's latest results show a mixed performance: while it achieved its highest annual operating cash flow in three years and net sales for the quarter, its profit after tax has declined sharply by 54.60% year-on-year, leading to a 'Sell' rating due to concerns over profitability and reliance on non-operating income.

NGL Fine Chem's latest results present a mixed picture. On one hand, the company achieved its highest annual operating cash flow in three years, amounting to Rs 35.82 crore, and reported net sales of Rs 104.19 crore for the quarter, which is the highest in the last five quarters. This indicates a positive trend in sales and operational cash generation.<BR><BR>However, there are significant challenges as well. The profit after tax (PAT) for the last six months has declined sharply by 54.60% year-on-year, which raises concerns about profitability. Additionally, a substantial portion of the profit before tax—over 53%—came from non-operating income, suggesting a reliance on income sources that may not be sustainable.<BR><BR>Overall, while there are some positive signs in terms of sales and cash flow, the decline in profitability and reliance on non-operating income indicate that the financial performance is not strong. The stock is currently rated as a 'Sell', reflecting the market's cautious outlook on the company's future prospects.

Is NGL Fine Chem overvalued or undervalued?

As of August 4, 2025, NGL Fine Chem is considered overvalued with a PE ratio of 38.04, an EV to EBITDA ratio of 23.60, and a Price to Book Value of 2.81, significantly higher than its peers, while also showing a year-to-date return of -28.62%, lagging behind the Sensex's 3.69%.

As of 4 August 2025, the valuation grade for NGL Fine Chem has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued, with a PE ratio of 38.04, an EV to EBITDA ratio of 23.60, and a Price to Book Value of 2.81. These figures suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, NGL Fine Chem's PE ratio is higher than Sun Pharma's 34.25 and significantly above Cipla's attractive PE of 22.7. The PEG ratio for NGL Fine Chem is notably low at 0.00, indicating a lack of growth expectations, which further supports the overvaluation claim. Additionally, while the stock has shown strong returns over the long term, its recent performance has lagged behind the Sensex, with a year-to-date return of -28.62% compared to the Sensex's 3.69%.

When is the next results date for NGL Fine Chem?

The next results date for NGL Fine Chem is 12 November 2025.

The next results date for NGL Fine Chem is scheduled for 12 November 2025.

How has been the historical performance of NGL Fine Chem?

NGL Fine Chem has shown an upward trend in net sales and total assets from Mar'20 to Mar'25, increasing from 151.69 Cr to 368.26 Cr, but profitability has declined, with profit after tax dropping from 56.72 Cr in Mar'21 to 21.12 Cr in Mar'25. Overall, while sales and assets have grown, the company faces challenges in maintaining profitability.

Answer:<BR>The historical performance of NGL Fine Chem shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>NGL Fine Chem's net sales have shown a general upward trend, increasing from 151.69 Cr in Mar'20 to 368.26 Cr in Mar'25, despite a dip in Mar'22. Total operating income followed a similar pattern, reaching 368.26 Cr in Mar'25. The raw material cost has also risen significantly, from 69.75 Cr in Mar'20 to 182.41 Cr in Mar'25, contributing to total expenditure growth from 132.30 Cr in Mar'20 to 334.39 Cr in Mar'25. Operating profit (PBDIT) peaked at 87.76 Cr in Mar'21 but has since declined to 42.50 Cr in Mar'25. Profit before tax mirrored this trend, decreasing from 77.59 Cr in Mar'21 to 27.71 Cr in Mar'25. Profit after tax also saw fluctuations, with a high of 56.72 Cr in Mar'21 and a drop to 21.12 Cr in Mar'25. The company's total liabilities increased from 153.62 Cr in Mar'20 to 433.39 Cr in Mar'25, while total assets rose from 153.62 Cr to 433.39 Cr in the same period. Cash flow from operating activities improved to 35.00 Cr in Mar'25, while net cash inflow/outflow remained stable at 0.00 Cr. Overall, NGL Fine Chem has experienced growth in sales and assets, but profitability has faced challenges in recent years.

Is NGL Fine Chem technically bullish or bearish?

As of December 3, 2025, the trend has shifted to mildly bearish due to bearish signals from MACD, KST, Bollinger Bands, and Dow Theory, despite daily moving averages remaining mildly bullish.

As of 3 December 2025, the technical trend has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by weekly MACD and KST indicators both showing mild bearishness, alongside bearish signals from Bollinger Bands and Dow Theory on a weekly basis. The daily moving averages remain mildly bullish, but the overall trend indicates weakness. The stock has underperformed significantly over the past month and year compared to the Sensex, reinforcing the bearish outlook.

Should I buy, sell or hold NGL Fine Chem Ltd?

Which are the latest news on NGL Fine Chem?

Which are the latest news on NGL Fine Chem?

Why is NGL Fine Chem falling/rising?

As of 21-Dec, NGL Fine Chem Ltd's stock price is at 1,279.35, down 2.35%, and has underperformed against the Sensex and its sector. The stock has seen a significant decline of 11.46% over the past three days, with reduced investor interest and concerning moving average trends indicating short-term weakness.

As of 21-Dec, NGL Fine Chem Ltd's stock price is falling, currently at 1,279.35, reflecting a decrease of 30.75 or 2.35%. The stock has been underperforming compared to the benchmark Sensex, with a performance today that is 3.1% lower than its sector. Over the past three days, the stock has experienced consecutive declines, totaling a significant drop of 11.46%. <BR><BR>Today, the stock opened with a loss of 2.1% and reached an intraday low of Rs 1,279.3. Additionally, the stock's moving averages indicate a concerning trend, as it is currently higher than the 200-day moving average but lower than the 5-day, 20-day, 50-day, and 100-day moving averages. This suggests a short-term weakness in price momentum. <BR><BR>Investor participation has also decreased, with delivery volume on December 18 falling by 20.2% compared to the 5-day average, indicating reduced interest from investors. Overall, these factors contribute to the stock's decline, as it has underperformed significantly over various time frames, including a year-to-date drop of 28.93% and a one-year decline of 37.90%.

Why is NGL Fine Chem falling/rising?

As of 22-Dec, NGL Fine Chem Ltd's stock price is rising to 1,308.00, reflecting a 2.24% increase after a trend reversal. Despite a year-to-date decline of 27.33%, the current upward movement may signal a potential recovery phase, although investor participation has decreased.

As of 22-Dec, NGL Fine Chem Ltd's stock price is rising, currently at 1,308.00, reflecting a change of 28.65 (2.24%) upward. This increase follows a trend reversal after three consecutive days of decline, indicating a potential shift in market sentiment. The stock outperformed its sector by 1.59% today, suggesting that it is gaining traction relative to its peers.<BR><BR>Additionally, the stock reached an intraday high of Rs 1347.8, marking a 5.35% increase during the trading session. However, it is important to note that while the stock is currently rising, it has experienced significant declines over longer periods, with a year-to-date drop of 27.33% and a one-year decrease of 34.69%. Despite these longer-term challenges, the current upward movement may be attributed to short-term trading dynamics and a potential recovery phase after recent losses. <BR><BR>Investor participation has shown a decline, with delivery volume falling by 13.84% against the five-day average, which could indicate cautious trading behavior. Nevertheless, the stock remains liquid enough for trading, which may support its current price rise.

Why is NGL Fine Chem Ltd falling/rising?

As of 23-Dec, NGL Fine Chem Ltd's stock price is 1,306.70, down 2.7 (-0.21%), with significant declines of 27.41% year-to-date and 33.43% over the past year, underperforming the Sensex. Despite increased investor participation, the stock shows a bearish trend and lacks upward momentum.

As of 23-Dec, NGL Fine Chem Ltd's stock price is currently at 1,306.70, reflecting a decrease of 2.7 (-0.21%). The stock has shown a significant decline over various time frames, with a year-to-date drop of 27.41% and a one-year decline of 33.43%. In contrast, the benchmark Sensex has increased by 9.45% year-to-date and 8.89% over the past year, indicating that NGL Fine Chem Ltd has underperformed relative to the market.<BR><BR>Today's trading performance has been described as inline with the sector, but the stock has not moved from its opening price of 1,306.70. Additionally, while the stock is trading higher than its 200-day moving average, it is below the 5-day, 20-day, 50-day, and 100-day moving averages, suggesting a bearish trend in the short to medium term.<BR><BR>Despite a rise in investor participation, with delivery volume increasing by 68.58% against the 5-day average, the overall performance metrics indicate a lack of upward momentum. The stock's liquidity remains adequate for trading, but the persistent declines in stock performance over the past weeks and months contribute to the current downward price movement.

Why is NGL Fine Chem Ltd falling/rising?

As of 24-Dec, NGL Fine Chem Ltd's stock price is rising to 1,327.20, reflecting a 1.57% increase. Despite today's gains, the stock has a year-to-date decline of 26.27% and shows decreasing investor participation, indicating a mixed outlook.

As of 24-Dec, NGL Fine Chem Ltd's stock price is rising, currently at 1,327.20, reflecting an increase of 20.5 points or 1.57%. This upward movement is supported by the stock outperforming its sector by 2% today and opening with a gain of 3.93%. Additionally, the stock reached an intraday high of Rs 1358, which indicates strong buying interest at the start of the trading session.<BR><BR>However, it is important to note that despite today's positive performance, the stock has shown a significant decline over longer periods, with a year-to-date drop of 26.27% and a one-year decline of 30.35%. The current price is also higher than the 200-day moving average, suggesting some bullish momentum in the short term, although it remains below the shorter-term moving averages (5-day, 20-day, 50-day, and 100-day).<BR><BR>Despite the rise today, there is a concerning trend of falling investor participation, as evidenced by a 79.1% decrease in delivery volume compared to the 5-day average. This decline in participation could indicate that the recent price increase may not be supported by strong buying interest, which could affect future price movements. Overall, while the stock is rising today, the longer-term performance and declining investor engagement present a mixed outlook.

Why is NGL Fine Chem Ltd falling/rising?

As of 25-Dec, NGL Fine Chem Ltd's stock price is rising, currently at 1,327.20 with a 1.57% increase today. However, it has seen significant declines over the past year, with a year-to-date drop of 26.27%, and decreased investor participation may indicate a lack of sustained interest despite today's gains.

As of 25-Dec, NGL Fine Chem Ltd's stock price is rising, as indicated by a current price of 1,327.20, which reflects a change of 20.5 or 1.57% increase. The stock opened with a significant gain of 3.93% today and reached an intraday high of Rs 1358. Additionally, it outperformed its sector by 2%. <BR><BR>Despite this positive movement today, it is important to note that the stock has experienced a decline over the longer term, with a year-to-date decrease of 26.27% and a one-year drop of 30.35%. However, the current upward trend may be attributed to today's strong performance, as it is trading higher than the 200-day moving averages, although it remains lower than the 5-day, 20-day, 50-day, and 100-day moving averages. <BR><BR>Investor participation has decreased, with delivery volume falling by 79.1% against the 5-day average, which may indicate a lack of sustained interest. Nonetheless, the stock's liquidity remains adequate for trading. Overall, the recent rise in price can be attributed to today's strong performance, despite the broader context of declining returns over the past year.

Why is NGL Fine Chem Ltd falling/rising?

As of 26-Dec, NGL Fine Chem Ltd's stock price is at 1,290.80, reflecting a decline of 2.74%. The stock has seen significant volatility and a substantial decrease in investor participation, contributing to its overall downward trend.

As of 26-Dec, NGL Fine Chem Ltd's stock price is falling, currently at 1,290.80, which reflects a decrease of 36.4 points or 2.74%. This decline is evident in the stock's performance today, where it underperformed its sector by 2.29%. The stock experienced significant volatility, with an intraday high of Rs 1,393.85 and a low of Rs 1,290.80, indicating a fluctuation of 6.22% throughout the day.<BR><BR>Over the past month, the stock has decreased by 3.26%, while its year-to-date performance shows a substantial decline of 28.29%. In the last year, the stock has fallen by 29.47%, contrasting sharply with the Sensex, which has gained 8.37% during the same period. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 77.47% compared to the 5-day average, suggesting a lack of interest from investors. The stock's moving averages indicate that it is currently lower than the 5-day, 20-day, 50-day, and 100-day averages, although it remains above the 200-day moving average. This combination of factors contributes to the current downward trend in NGL Fine Chem Ltd's stock price.